erythropoietin stimulating agents (ESAs)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for erythropoietin stimulating agents (ESAs), covering 2018-08-15 to 2018-08-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs) [Phase 4]